Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
0.9110
-0.1290 (-12.40%)
At close: Oct 19, 2026, 4:00 PM EDT
0.9255
+0.0145 (1.59%)
After-hours: Oct 19, 2026, 4:00 PM EDT
Cellectis Market Cap
Cellectis has a market cap or net worth of $77.6 million as of October 19, 2026. Its market cap has decreased by 73.90% in one year.
Market Cap
77.60M
Enterprise Value
-7.18M
1-Year Change
-73.90%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $77.60M, a decrease of -94.23%. That is a compound annual growth rate of -21.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 75.60M | -78.41% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 92.15M |
| PMV Pharmaceuticals | 91.37M |
| Rani Therapeutics Holdings | 89.30M |
| Neumora Therapeutics | 89.03M |
| Corbus Pharmaceuticals Holdings | 87.42M |
| Rallybio | 86.45M |
| Conexeu Sciences | 86.31M |
| Tenaya Therapeutics | 85.36M |